The Better Assessment of Illness Study for Delirium Severity

Study Design, Procedures, and Cohort Description

the BASIL Study Group

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background/Objectives: To describe the design, procedures, and cohort for the Better ASsessment of ILlness -(BASIL) study, which is conducted to develop and test new delirium severity measures, compare them with existing measures, and examine related clinical outcomes. Methods: Prospective cohort study with 1 year follow-up of study participants at a large teaching hospital in Boston, Massachusetts. After brief cognitive testing and the Delirium Symptom Interview, delirium and delirium severity were rated daily in the hospital using the Confusion Assessment Method (CAM) and CAM-Severity score, the Delirium Rating Scale-Revised-98 (DRS-R-98), and the Memorial Delirium Assessment Scale (MDAS). Other key study variables included comorbidity, physical function (basic and instrumental activities of daily living [ADL]), ratings of subjective health and well-being, and clinical outcomes (length of stay, 30 day rehospitalization, nursing home admission, healthcare utilization). Follow-up interviews occurred at 1- and 12-month with patients and families. In 42 patient interviews, inter-rater reliability for key variables was assessed. Results: Of 768 eligible patients approached, 469 were screened and 352 enrolled, yielding an overall study response rate of 67% for potentially eligible participants. The mean participant was 80.3 years old (SD 6.8) and 203 (58%) were female. The majority of patients were medically complex with Charlson Comorbidity Scores ≥2 (192 patients, 55%), and 102 (29%) met criteria for dementia. Inter-rater reliability assessments (n = 42 pairs) were high for overall ratings of presence or absence of delirium by CAM (κ = 1.0), delirium severity by DRS-R-98 and MDAS (weighted kappa, κ = 1.0 for each) and for ADL impairment (κ = 1.0). For eligible participants at each time point, 278 out of 308 (90%) completed the 1-month follow-up and 132 out of 256 (53%) have completed the 12-month follow-up to date, which is still in progress. Among those who completed interviews, there was only 1-3% missing data on most major outcomes (delirium, basic ADL, and readmission). Conclusion: The BASIL study presents an innovative effort to advance the conceptualization and measurement of delirium severity. Unique strengths include the diverse cohort with complete high quality data and longitudinal follow-up, along with detailed collection of multiple delirium measures daily during hospitalization.

Original languageEnglish (US)
Pages (from-to)20-29
Number of pages10
JournalGerontology
Volume65
Issue number1
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Delirium
Confusion
Activities of Daily Living
Interviews
Comorbidity
Diagnostic Self Evaluation
Nursing Homes
Teaching Hospitals
Dementia
Length of Stay
Hospitalization
Cohort Studies

Keywords

  • Cohort description
  • Data quality
  • Delirium
  • Delirium severity rating
  • Methods
  • Study design

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

The Better Assessment of Illness Study for Delirium Severity : Study Design, Procedures, and Cohort Description. / the BASIL Study Group.

In: Gerontology, Vol. 65, No. 1, 01.01.2019, p. 20-29.

Research output: Contribution to journalArticle

@article{08f69b05150746c380af07b0cde65a95,
title = "The Better Assessment of Illness Study for Delirium Severity: Study Design, Procedures, and Cohort Description",
abstract = "Background/Objectives: To describe the design, procedures, and cohort for the Better ASsessment of ILlness -(BASIL) study, which is conducted to develop and test new delirium severity measures, compare them with existing measures, and examine related clinical outcomes. Methods: Prospective cohort study with 1 year follow-up of study participants at a large teaching hospital in Boston, Massachusetts. After brief cognitive testing and the Delirium Symptom Interview, delirium and delirium severity were rated daily in the hospital using the Confusion Assessment Method (CAM) and CAM-Severity score, the Delirium Rating Scale-Revised-98 (DRS-R-98), and the Memorial Delirium Assessment Scale (MDAS). Other key study variables included comorbidity, physical function (basic and instrumental activities of daily living [ADL]), ratings of subjective health and well-being, and clinical outcomes (length of stay, 30 day rehospitalization, nursing home admission, healthcare utilization). Follow-up interviews occurred at 1- and 12-month with patients and families. In 42 patient interviews, inter-rater reliability for key variables was assessed. Results: Of 768 eligible patients approached, 469 were screened and 352 enrolled, yielding an overall study response rate of 67{\%} for potentially eligible participants. The mean participant was 80.3 years old (SD 6.8) and 203 (58{\%}) were female. The majority of patients were medically complex with Charlson Comorbidity Scores ≥2 (192 patients, 55{\%}), and 102 (29{\%}) met criteria for dementia. Inter-rater reliability assessments (n = 42 pairs) were high for overall ratings of presence or absence of delirium by CAM (κ = 1.0), delirium severity by DRS-R-98 and MDAS (weighted kappa, κ = 1.0 for each) and for ADL impairment (κ = 1.0). For eligible participants at each time point, 278 out of 308 (90{\%}) completed the 1-month follow-up and 132 out of 256 (53{\%}) have completed the 12-month follow-up to date, which is still in progress. Among those who completed interviews, there was only 1-3{\%} missing data on most major outcomes (delirium, basic ADL, and readmission). Conclusion: The BASIL study presents an innovative effort to advance the conceptualization and measurement of delirium severity. Unique strengths include the diverse cohort with complete high quality data and longitudinal follow-up, along with detailed collection of multiple delirium measures daily during hospitalization.",
keywords = "Cohort description, Data quality, Delirium, Delirium severity rating, Methods, Study design",
author = "{the BASIL Study Group} and Hshieh, {Tammy T.} and Fong, {Tamara G.} and Schmitt, {Eva M.} and Marcantonio, {Edward R.} and D'Aquila, {Madeline L.} and Jacqueline Gallagher and Guoquan Xu and Guo, {Yun R.} and Abrantes, {Tatiana F.} and Bertrand, {Sylvie E.} and Jones, {Richard N.} and Inouye, {Sharon K.} and Hshie, {Tammy T.} and Annie Racine and Dena Schulman-Green and Tabloski, {Patricia A.} and Thomas Travison and Brett Armstrong and Angelee Butters and Jennifer Kettell and Jacqueline Nee and Katelyn Parisi and Margaret Vella and Lauren Weiner and Yun Gou and Douglas Tommet and Brown, {Charles H.} and Sevdenur Cizginer and Diane Clark and Flaherty, {Joseph H.} and Anne Gleason and Kolanowski, {Ann M.} and Neufeld, {Karen J.} and O'Connor, {Margaret G.} and Pisani, {Margaret A.} and Thomas Robinson and Joe Verghese and Heidi Wald and Gordon, {Sharon M.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1159/000490386",
language = "English (US)",
volume = "65",
pages = "20--29",
journal = "Gerontology",
issn = "0304-324X",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - The Better Assessment of Illness Study for Delirium Severity

T2 - Study Design, Procedures, and Cohort Description

AU - the BASIL Study Group

AU - Hshieh, Tammy T.

AU - Fong, Tamara G.

AU - Schmitt, Eva M.

AU - Marcantonio, Edward R.

AU - D'Aquila, Madeline L.

AU - Gallagher, Jacqueline

AU - Xu, Guoquan

AU - Guo, Yun R.

AU - Abrantes, Tatiana F.

AU - Bertrand, Sylvie E.

AU - Jones, Richard N.

AU - Inouye, Sharon K.

AU - Hshie, Tammy T.

AU - Racine, Annie

AU - Schulman-Green, Dena

AU - Tabloski, Patricia A.

AU - Travison, Thomas

AU - Armstrong, Brett

AU - Butters, Angelee

AU - Kettell, Jennifer

AU - Nee, Jacqueline

AU - Parisi, Katelyn

AU - Vella, Margaret

AU - Weiner, Lauren

AU - Gou, Yun

AU - Tommet, Douglas

AU - Brown, Charles H.

AU - Cizginer, Sevdenur

AU - Clark, Diane

AU - Flaherty, Joseph H.

AU - Gleason, Anne

AU - Kolanowski, Ann M.

AU - Neufeld, Karen J.

AU - O'Connor, Margaret G.

AU - Pisani, Margaret A.

AU - Robinson, Thomas

AU - Verghese, Joe

AU - Wald, Heidi

AU - Gordon, Sharon M.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background/Objectives: To describe the design, procedures, and cohort for the Better ASsessment of ILlness -(BASIL) study, which is conducted to develop and test new delirium severity measures, compare them with existing measures, and examine related clinical outcomes. Methods: Prospective cohort study with 1 year follow-up of study participants at a large teaching hospital in Boston, Massachusetts. After brief cognitive testing and the Delirium Symptom Interview, delirium and delirium severity were rated daily in the hospital using the Confusion Assessment Method (CAM) and CAM-Severity score, the Delirium Rating Scale-Revised-98 (DRS-R-98), and the Memorial Delirium Assessment Scale (MDAS). Other key study variables included comorbidity, physical function (basic and instrumental activities of daily living [ADL]), ratings of subjective health and well-being, and clinical outcomes (length of stay, 30 day rehospitalization, nursing home admission, healthcare utilization). Follow-up interviews occurred at 1- and 12-month with patients and families. In 42 patient interviews, inter-rater reliability for key variables was assessed. Results: Of 768 eligible patients approached, 469 were screened and 352 enrolled, yielding an overall study response rate of 67% for potentially eligible participants. The mean participant was 80.3 years old (SD 6.8) and 203 (58%) were female. The majority of patients were medically complex with Charlson Comorbidity Scores ≥2 (192 patients, 55%), and 102 (29%) met criteria for dementia. Inter-rater reliability assessments (n = 42 pairs) were high for overall ratings of presence or absence of delirium by CAM (κ = 1.0), delirium severity by DRS-R-98 and MDAS (weighted kappa, κ = 1.0 for each) and for ADL impairment (κ = 1.0). For eligible participants at each time point, 278 out of 308 (90%) completed the 1-month follow-up and 132 out of 256 (53%) have completed the 12-month follow-up to date, which is still in progress. Among those who completed interviews, there was only 1-3% missing data on most major outcomes (delirium, basic ADL, and readmission). Conclusion: The BASIL study presents an innovative effort to advance the conceptualization and measurement of delirium severity. Unique strengths include the diverse cohort with complete high quality data and longitudinal follow-up, along with detailed collection of multiple delirium measures daily during hospitalization.

AB - Background/Objectives: To describe the design, procedures, and cohort for the Better ASsessment of ILlness -(BASIL) study, which is conducted to develop and test new delirium severity measures, compare them with existing measures, and examine related clinical outcomes. Methods: Prospective cohort study with 1 year follow-up of study participants at a large teaching hospital in Boston, Massachusetts. After brief cognitive testing and the Delirium Symptom Interview, delirium and delirium severity were rated daily in the hospital using the Confusion Assessment Method (CAM) and CAM-Severity score, the Delirium Rating Scale-Revised-98 (DRS-R-98), and the Memorial Delirium Assessment Scale (MDAS). Other key study variables included comorbidity, physical function (basic and instrumental activities of daily living [ADL]), ratings of subjective health and well-being, and clinical outcomes (length of stay, 30 day rehospitalization, nursing home admission, healthcare utilization). Follow-up interviews occurred at 1- and 12-month with patients and families. In 42 patient interviews, inter-rater reliability for key variables was assessed. Results: Of 768 eligible patients approached, 469 were screened and 352 enrolled, yielding an overall study response rate of 67% for potentially eligible participants. The mean participant was 80.3 years old (SD 6.8) and 203 (58%) were female. The majority of patients were medically complex with Charlson Comorbidity Scores ≥2 (192 patients, 55%), and 102 (29%) met criteria for dementia. Inter-rater reliability assessments (n = 42 pairs) were high for overall ratings of presence or absence of delirium by CAM (κ = 1.0), delirium severity by DRS-R-98 and MDAS (weighted kappa, κ = 1.0 for each) and for ADL impairment (κ = 1.0). For eligible participants at each time point, 278 out of 308 (90%) completed the 1-month follow-up and 132 out of 256 (53%) have completed the 12-month follow-up to date, which is still in progress. Among those who completed interviews, there was only 1-3% missing data on most major outcomes (delirium, basic ADL, and readmission). Conclusion: The BASIL study presents an innovative effort to advance the conceptualization and measurement of delirium severity. Unique strengths include the diverse cohort with complete high quality data and longitudinal follow-up, along with detailed collection of multiple delirium measures daily during hospitalization.

KW - Cohort description

KW - Data quality

KW - Delirium

KW - Delirium severity rating

KW - Methods

KW - Study design

UR - http://www.scopus.com/inward/record.url?scp=85060174984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060174984&partnerID=8YFLogxK

U2 - 10.1159/000490386

DO - 10.1159/000490386

M3 - Article

VL - 65

SP - 20

EP - 29

JO - Gerontology

JF - Gerontology

SN - 0304-324X

IS - 1

ER -